Colorimetric-based detection of Ureaplasma

urealyticum using gold nanoparticles by ghorbanzadeh, Nahid et al.
IET Nanobiotechnology
Research Article
Colorimetric-based detection of Ureaplasma
urealyticum using gold nanoparticles
ISSN 1751-8741
Received on 14th April 2019
Revised 20th July 2019
Accepted on 13th August 2019
E-First on 16th December 2019
doi: 10.1049/iet-nbt.2019.0088
www.ietdl.org
Nahid Ghorbanzadeh1, Amir Peymani2, Hossein Ahmadpour-Yazdi3,4 
1Student Research Committee, Qazvin University of Medical Sciences, Qazvin, Iran
2Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
3Medical Biotechnology Department, Faculty of Paramedical Sciences, Qazvin University of Medical Sciences, Qazvin, Iran
4Medical Microbiology Research Center, Qazvin University of Medical Sciences, Qazvin, Iran
 E-mail: hahmadpour@qums.ac.ir
Abstract: Ureaplasma urealyticum (uu) is one of the most common agents of urogenital infections and is associated with
complications such as infertility, spontaneous abortion and other sexually transmitted diseases. Here, a DNA sensor based on
oligonucleotide target-specific gold nanoparticles (AuNPs) was developed, in which the dispersed and aggregated states of
oligonucleotide-functionalised AuNPs were optimised for the colorimetric detection of a polymerase chain reaction (PCR)
amplicon of U. urealyticum DNA. A non-cross-linking approach utilising a single Au-nanoprobe specific of the urease gene was
utilised and the effect of a PCR product concentration gradient evaluated. Results from both visual and spectral analyses
showed that target–Au-nanoprobe hybrids were stable against aggregation after adding the inducer. Furthermore, when a non-
target PCR product was used, the peak position shifted and salt-induced aggregation occurred. The assay's limit of detection of
the assay was 10 ng with a dynamic range of 10–60 ng. This procedure provides a rapid, facile and low-cost detection format,
compared to methods currently used for the identification of U. urealyticum.
1 Introduction
Ureaplasma urealyticum (uu) is one of the most common human
urogenital pathogens and mostly acquired via sexual contact [1]. It
is a part of the normal vaginal flora with a worldwide colonisation
value ranging from 60 to 80% [2]. Despite this, U. urealyticum has
frequently been isolated in lower urogenital tract infections of both
men and women [3]. Furthermore, several studies have implied the
microorganism to be associated with additional pathological
conditions such as: postoperative wound infections, chronic lung
disease in neonates [4], non-gonococcal urethritis [5], prostatitis
[6] and intrauterine infections including: endometritis, pelvic
inflammatory disease [7], chorioamnionitis [8] and postpartum
fever, leading to major complications such as preterm birth [9],
spontaneous abortion, infertility [10] and perinatal mortality [11].
The genus Ureaplasma belongs to the family
Mycoplasmataceae [12] and contains two common species, U.
parvum and U. urealyticum. U. parvum is a commensal or low
pathogenic species that is commonly found in healthy men and
women, while U. urealyticum is a recognised pathogen that is less
common [2]. The average global prevalence of this pathogen in
people with infertility, adverse pregnancy outcomes and urinary
tract infections is estimated to be 30–50% [13]. The significant
clinical importance of this microorganism combined with its
potential for asymptomatic genitourinary system colonisation
makes its timely and sensitive diagnosis an urgent concern [14].
Currently, U. urealyticum is detected through two major
strategies: bacterial culture-based phenotypic methods and nucleic
acid detection assays. Culture is the gold standard for the
diagnosis, but this organism is fastidious, requiring an intensely
quality-controlled medium and several days of incubation;
therefore, culture-based detection is costly and laborious [15]. In
contrast, molecular-based methods like polymerase chain reaction
(PCR) and real-time PCR using Ureaplasma-specific sequences
provide a quick diagnosis with high sensitivity; and however, these
methods are considered limited by the need for expert persons and
by high equipment costs [16]. The distinct drawbacks of both
approaches indicate a need for better detection solutions regarding
this pathogen.
Lately, considerable interest has arisen in the utilisation of gold
nanoparticles (AuNPs) for pathogen detection [17–20]. These
assays mainly rely on the basic principles of surface plasmon
resonance (SPR) of AuNPs to detect changes in nanoparticle
aggregation state. AuNPs functionalised with thiol-modified
oligonucleotides (Au-nanoprobes) possess unique optical
properties and can be easily observed by the naked eye, with no
requirement for complicated tools. These are used as signal
transduction elements in the identification of nucleic sequences
[21] using either cross-linking [22] or non-cross-linking (NCL)
approaches [23]. In NCL colorimetric detection, the hybridisation
of a specific complementary target to an Au-nanoprobe leads to
electrosteric stabilisation of the AuNPs and resistance to salt-
induced aggregation [21, 24]. This assay offers high sensitivity and
specificity at much lower expense than with traditional methods
[25].
The pronounced scattering intensity of AuNPs results from the
collective oscillation of conduction electrons [26]. As the
resonance band depends on AuNP size and shape [27], as well as
the refractive index conditions in their close proximity [28, 29], it
is possible to detect even single coupling events between
functionalised nanoparticles [30]. Spherical AuNPs with an
average size of 9–99 nm have been observed to absorb at 517–557 
nm [31]. The AuNPs most easily synthesised, and therefore most
commonly employed in biosensors, have sizes <60 nm and an
absorbance peak at around 520 nm [32]. Monodisperse AuNP
solutions have SPR peaks at almost 525 nm (red colour); in
presence of salt, aggregate (blue colour) and the surface plasmon
band is shifted to longer wavelengths (red shift) [33].
In the current study, we attempt to develop a colorimetric assay
using AuNP-oligo probes for the first time to detection of U.
urealyticum. This method uses the NCL approach and targets the
urease gene of U. urealyticum using a specific probe.
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